Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 119 Records) |
| Query Trace: Lung Neoplasms and STK11[original query] |
|---|
| Molecular Characteristics and the Effect of KRAS Mutation on the Prognosis of Immunotherapy in Non-Small Cell Lung Cancer in Xinjiang, China. OncoTargets and therapy 2022 9 15 1021-1032. Gu Guomin, Yu Bo, Wan Hua, Lu Suqiong, Zhu Xiaodan, Zhao Yan, Fuxi Yujing, Liu Chunli |
| Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer. Journal of thoracic disease 2022 7 14 (6): 1772-1783. Malhotra Jyoti, Ryan Brid, Patel Malini, Chan Nancy, Guo Yanxiang, Aisner Joseph, Jabbour Salma K, Pine Shar |
| Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer. European journal of cancer (Oxford, England : 1990) 2022 Jun 172 85-95. Rosellini Pietro, Amintas Samuel, Caumont Charline, Veillon Rémi, Galland-Girodet Sigolène, Cuguillière Alain, Nguyen Laurent, Domblides Charlotte, Gouverneur Amandine, Merlio Jean-Philippe, Bezin Julien, Girodet Pierre-Olivi |
| Genomic landscape of lung adenocarcinomas in different races. Frontiers in oncology 2022 12 946625. Shi Huashan, Seegobin Karan, Heng Fei, Zhou Kexun, Chen Ruqin, Qin Hong, Manochakian Rami, Zhao Yujie, Lou Yany |
| Probing Mutant KRAS, STK11, KEAP1 in NSCLC. Cancer discovery 2022 Aug OF1. Authors are not available |
| Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance. Japanese journal of clinical oncology 2023 9 . Jie Zheng, Yuanyao Dou, Daijuan Huang, Yubo Wang, Rui Han, Chen Hu, Mengxiao Zhu, Conghua Lu, Caiyu Lin, Di Wu, Yihui Liu, Huan Tang, Tingting He, Weilin Jiang, Yong |
| Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 4 . Biagio Ricciuti, Arielle Elkrief, Joao Alessi, Xinan Wang, Yvonne Li, Hersh Gupta, Daniel M Muldoon, Arrien A Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana Barrichello, Victor R Vaz, Malini Gandhi, Elinton Lee, Geoffrey I Shapiro, Hyesun Park, Mizuki Nishino, James Lindsay, Kristen D Felt, Bijaya Sharma, Andrew D Cherniack, Scott Rodig, Daniel R Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A Janne, Adam J Schoenfeld, Lynette M Sholl, Mark M Awad, Michael L Che |
| A systematic review of genetic ancestry as a risk factor for incidence of non-small cell lung cancer in the US. Frontiers in genetics 2023 4 14 1141058. Breanna A James, Jennie L Williams, Barbara Nemesu |
| Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting. BMC cancer 2023 4 23 (1): 352. Julian Cristina, Pal Navdeep, Gershon Anda, Evangelista Marie, Purkey Hans, Lambert Peter, Shi Zhen, Zhang Qi |
| Concurrent Mutations in STK11 and KEAP1 Cause Treatment Resistance in KRAS Wild-type Non-small-cell Lung Cancer. Internal medicine (Tokyo, Japan) 2023 3 . Sumii Masahiko, Namba Masashi, Tokumo Kentaro, Yamauchi Masami, Okamoto Wataru, Hattori Noboru, Sugiyama Kazuhi |
| [Gene mutation profiles and clinicopathological features of patients with non-small cell lung cancer harboring KRAS G12C mutation: a single-center retrospective study]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2023 2 52 (2): 117-123. Guo L Y, Xiang C, Zhao R Y, Chen S N, Ma S J, Han Y |
| Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers. Targeted oncology 2023 11 . Marine Marchal, Vincent Leroy, Hélène Behal, Eric Dansin, Nicolas Paris, Soraya Bordier, Sarah Humez, Fabienne Escande, Clément Gauvain, Alexis B Cort |
| Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations. Cancers 2023 11 15 (22): . Soojin Jun, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Juhee Cho, Hyun Ae Ju |
| Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort. Tumori 2023 10 3008916231204441. Andrea Olsen, Alexandra Lebedeva, Polina Nosova, Vladislav Nikulin, Margarita Sharova, Ekaterina Ignatova, Vladislav Mileyko, Maxim Ivan |
| STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer. JCO precision oncology 2023 1 7 e2200273. Katipally Rohan R, Spurr Liam F, Gutiontov Stanley I, Turchan William Tyler, Connell Philip, Juloori Aditya, Malik Renuka, Binkley Michael S, Jiang Alice L, Rouhani Sherin J, Chervin Carolina Soto, Wanjari Pankhuri, Segal Jeremy P, Ng Victor, Loo Billy W, Gomez Daniel R, Bestvina Christine M, Vokes Everett E, Ferguson Mark K, Donington Jessica S, Diehn Maximilian, Pitroda Sean |
| Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival. JCO precision oncology 2023 1 7 e2200540. De Brian, Farooqi Ahsan S, Mitchell Kyle G, Ludmir Ethan B, Lewis Jeff, Rinsurongkawong Waree, Rinsurongkawong Vadeerat, Lee J Jack, Swisher Stephen G, Gibbons Don L, Zhang Jianjun, Le Xiuning, Elamin Yasir Y, Gomez Daniel R, Ning Matthew S, Lin Steven H, Liao Zhongxing, Chang Joe Y, Vaporciyan Ara A, Heymach John V, Antonoff Mara B, Gandhi Saumil |
| Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC. Annals of oncology : official journal of the European Society for Medical Oncology 2023 1 . Mok T S K, Lopes G, Cho B C, Kowalski D M, Kasahara K, Wu Y-L, de Castro G, Turna H Z, Cristescu R, Aurora-Garg D, Loboda A, Lunceford J, Kobie J, Ayers M, Pietanza M C, Piperdi B, Herbst R |
| Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy. Journal of cancer research and clinical oncology 2024 9 150 (9): 413. Guomin Gu, Chunling Liu, Xiaodan Zhu, Yan Yang, Shuming Song, Yan Zhao, Gang S |
| Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology. Lung cancer (Amsterdam, Netherlands) 2024 9 196 107935. Jennifer A Marks, Nishant Gandhi, Balazs Halmos, Melina E Marmarelis, So Yeon Kim, Lyudmila Bazhenova, Suresh S Ramalingam, Joanne Xiu, Phillip Walker, Matthew J Oberley, Patrick C Ma, Stephen V L |
| Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non-Small Cell Lung Cancer. Cancer research communications 2024 8 . Daniel R Principe, Mary M Pasquinelli, Ryan H Nguyen, Hidayatullah G Munshi, Alicia Hulbert, Alexandre F Aissa, Frank Weinbe |
| Ancestry-, Sex-, and Age-Based Differences of Gene Alterations in NSCLC: From the Real-World Data of Cancer Genomic Profiling Tests. Journal of the National Comprehensive Cancer Network : JNCCN 2024 8 1-10. Keita Miura, Takehito Shukuya, Ray Greenstein, Ben Kaplan, Heather Wakelee, Kana Kurokawa, Kazuyuki Furuta, Shunsuke Kato, Junghee Suh, Smruthy Sivakumar, Ethan S Sokol, David P Carbone, Kazuhisa Takahas |
| Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology-proven malignant pleural effusions. Cancer cytopathology 2024 8 . Cristiana M Pineda, Adnan Majid, Daniel B Costa, Paul A VanderLa |
| Predictive value and molecular correlates of MYC immunohistochemistry and copy number gain in non-small cell lung carcinomas treated with immunotherapy. Lung cancer (Amsterdam, Netherlands) 2024 8 195 107927. Julia Naso, Aakash Desai, Caleb J Smith, Yash P Ashara, Stephen Yip, Ying-Chun |
| TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations. Frontiers in oncology 2024 8 14 1357583. Armin Frille, Myriam Boeschen, Hubert Wirtz, Mathias Stiller, Hendrik Bläker, Maximilian von Laffe |
| Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Cancers 2024 7 16 (13): . ErinMarie O Kimbrough, Julian A Marin-Acevedo, Leylah M Drusbosky, Ariana Mooradian, Yujie Zhao, Rami Manochakian, Yanyan L |
| SWI/SNF family mutations in advanced NSCLC: genetic characteristics and immune checkpoint inhibitors' therapeutic implication. ESMO open 2024 6 9 (6): 103472. L-L Pang, H-Q Zhou, Y-X Zhang, W-T Zhuang, F Pang, L-J Chen, J Liao, Y-H Huang, T-Q Mao, Z-H Mai, L Zhang, W-F Fa |
| Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancer. Med (New York, N.Y.) 2024 5 . Jie Zhao, Lu Wang, Anda Zhou, Shidi Wen, Wenfeng Fang, Li Zhang, Jianchun Duan, Hua Bai, Jia Zhong, Rui Wan, Boyang Sun, Wei Zhuang, Yiwen Lin, Danming He, Lina Cui, Zhijie Wang, Jie Wa |
| Prognostic implications of STK11 with different mutation status and its relationship with tumor-infiltrating immune cells in non-small cell lung cancer. Frontiers in immunology 2024 5 15 1387896. Jianqing Zheng, Yujie Deng, Bifen Huang, Xiaohui Ch |
| Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses. BMC cancer 2024 4 24 (1): 491. Ke Xu, Weinan Lu, Airu Yu, Hongwei Wu, Jie |
| Combining genomic biomarkers to guide immunotherapy in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 2 . Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert F Smit, Lodewyk F A Wessels, Edwin Cuppen, Joachim G J V Aerts, Emile E Voe |
- Page last reviewed:Feb 1, 2024
- Content source: